In Brief: Guidant/EndoVascular Technologies
This article was originally published in The Gray Sheet
Executive Summary
Guidant/EndoVascular Technologies: EVT shareholders approve Guidant's proposed acquisition of the company, Guidant reports Dec. 19. Announced Oct. 6, the $170 mil. deal calls for an exchange of 0.3154 shares of Guidant for each EVT share ("The Gray Sheet" Oct. 13 I&W-1). Guidant says it issues roughly 2.7 mil. shares in connection with the purchase. EVT CEO Jim Fitzimmons is named a Guidant senior VP and general manager of the company's Cardiac & Vascular Surgery Group, formerly known as the Minimally Invasive Systems Group...